| C01EB24 |
C01EB24 Mavacamten |
| C01EB25 |
C01EB25 Acoramidis |
| C01EX |
C01EX Other cardiac combination products |
| C02 |
C02 Antihypertensives |
| C02A |
C02A Antiadrenergic agents, centrally acting |
| C02AA |
C02AA Rauwolfia alkaloids |
| C02AA01 |
C02AA01 rescinnamine |
| C02AA02 |
C02AA02 reserpine |
| C02AA03 |
C02AA03 combinations of rauwolfia alkaloids |
| C02AA04 |
C02AA04 rauwolfia alkaloids, whole root |
| C02AA05 |
C02AA05 deserpidine |
| C02AA06 |
C02AA06 methoserpidine |
| C02AA07 |
C02AA07 bietaserpine |
| C02AA52 |
C02AA52 reserpine, combinations |
| C02AA53 |
C02AA53 combinations of rauwolfia alkoloids, combinations |
| C02AA57 |
C02AA57 bietaserpine, combinations |
| C02AB |
C02AB Methyldopa |
| C02AB01 |
C02AB01 methyldopa (levorotatory) |
| C02AB02 |
C02AB02 methyldopa (racemic) |
| C02AC |
C02AC Imidazoline receptor agonists |
| C02AC01 |
C02AC01 clonidine |
| C02AC02 |
C02AC02 guanfacine |
| C02AC04 |
C02AC04 tolonidine |
| C02AC05 |
C02AC05 moxonidine |
| C02AC06 |
C02AC06 Rilmenidine |
| C02B |
C02B Antiadrenergic Agents, Ganglion-Blocking |
| C02BA |
C02BA Sulfonium Derivatives |
| C02BA01 |
C02BA01 trimetaphan |
| C02BB |
C02BB Secondary And Tertiary Amines |
| C02BB01 |
C02BB01 mecamylamine |